Trial intelligence / Profile preview

HL-1186 for Postoperative Analgesia in Orthopedic Surgery

NCT07699601Phase 3Recruiting

Sponsor
Shanghai Huilun Pharmaceutical Co., Ltd.
Start
May 2026
Primary completion
Oct 2026
Countries
1
01

Overview

A Phase 3 trial of HL-1186 in postoperative pain, sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started May 2026; status: recruiting.

02

Drugs

HL-1186
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07699601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07699601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call